Utilitzem cookies
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Ho sabíeu?
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Significats de Enbrel en anglès
portuguès
etanercepte A genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis.
Veure'n mésÚs de Enbrel en anglès
1
Amgen is also facing an investigation into its Enbrel marketing practices.
2
It was compared with placebo in those late-stage studies, rather than to Enbrel.
3
The same dangers were previously printed in bold-face type in Enbrel's package insert label.
4
Safety issues already hang over Enbrel, which carries a strong warning about potentially fatal infections.
5
The same dangers have previously been printed in bold-face type in Enbrel's package insert label.
6
Injected arthritis drug Enbrel was hit by competition from cheaper biosimilars outside the United States.
7
Rival Humira must be injected once every two weeks and Enbrel is injected once a week.
8
Wyeth also benefited from its Enbrel drug, for which it shares rights with Amgen Inc AMGN.O.
9
Wyeth co-markets Enbrel in the United States.
10
The man charged BBC reporter Jonathan Gibson £250 for a box of Enbrel, a specialist arthritis drug.
11
Drugs made by Amgen, which is headquartered in California, include Vectibix for cancer and arthritis treatment Enbrel.
12
It was the first trial pitting J&J's ustekinumab against Enbrel, a blockbuster treatment for the chronic skin condition.
13
It will make a number of key products including biotechnology drug Enbrel for the treatment of severe rheumatoid arthritis.
14
Amgen said it was confident Enbrel would continue to grow in the face of anticipated new competition this year.
15
It was the first trial to pit J&J's ustekinumab against Enbrel, a blockbuster treatment for the chronic skin condition.
16
That was deemed statistically superior to the 57 percent of those in the Enbrel group who obtained such relief.